MedPageToday SARS-CoV-2 infection itself played minor role in OHCA survival rates in Seattle
Epidemiological records suggest that Seattle’s drop in out-of-hospital cardiac arrest (OHCA) survival during the pandemic could be largely explained by indirect factors such as treatment delays, not acute SARS-CoV-2 infections.
While instances of EMS-treated OHCA tended to track closely with community SARS-CoV-2 levels and acute SARS-CoV-2 infection in 2020-2021, only approximately 5% of people with OHCA, whether treated or dead on arrival (DOA), actually had evidence of COVID-19, reported researchers led by Jennifer Liu, MPH, of Public Health-Seattle & King County in Washington.
The group estimated that acute infection was responsible for 18.5% of the downturn in OHCA survival rates when comparing prepandemic (2018-2019) versus pandemic (2020-2021) periods. In contrast, 68.2% of the survival decline was mediated by adverse trends in so-called “Utstein elements” such as public location of OHCA, witness status, non-EMS automated external defibrillator use, and EMS response intervals.
“In this cohort study of COVID-19 and OHCA, a substantial proportion of the higher OHCA incidence and lower survival during the pandemic was not directly due to SARS-CoV-2 infection but indirect factors that challenged OHCA prevention and treatment,” the investigators concluded from their study, published in JAMA Network
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.